Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision		 Previous revision
plaquenil [2020/06/25 01:44] – [Recommended Screening Procedures] Scott Larsonplaquenil [2025/06/14 03:55] (current) – [Recommended Screening Procedures] Scott Larson
Line 31: Line 31:
     * localized thinning of parafoveal region especially the outer-segments and RPE structural lines     * localized thinning of parafoveal region especially the outer-segments and RPE structural lines
     * loss of the inner-/outer-segment line may be early sign     * loss of the inner-/outer-segment line may be early sign
-    * {{:oct_plaquenil_toxicity.png?400|}}+    * {{:oct_plaquenil_toxicity.jpg?|}}
   * mfERG   * mfERG
     * Especially in suspicious or unreliable visual field loss     * Especially in suspicious or unreliable visual field loss
Line 37: Line 37:
   * Fundus Autofluorescence   * Fundus Autofluorescence
     * Increased autofluorescence possibly from accumulation of outersegment debris     * Increased autofluorescence possibly from accumulation of outersegment debris
-    * {{::fundus_autofluorescence_plaquenil.png?300 |}}+    * {{::fundus_autofluorescence_plaquenil.jpg?|}}
  
 ===== Tests NOT recommended for screening ===== ===== Tests NOT recommended for screening =====